Refined Tissue Chemistry Lets Mass Spectrometry Maps Reveal Tumor Metabolism

Researchers have refined a chemical preparation step that makes it far easier to map small, difficult-to-detect metabolites directly inside intact tissue, and they used the improved method to visualize metabolic differences between tumors and healthy tissue in mouse models of metastatic cancer. The work, published in Cancer Cell International, describes an optimized on-tissue chemical derivatization workflow for matrix-assisted laser desorption/ionization mass spectrometry imaging, or MALDI-MSI, using two reagents known as 4-APEBA and the carbodiimide crosslinker EDC.

MALDI-MSI is widely used in metabolomics because it can characterize the spatial distribution of molecules at high resolution directly from a tissue section, without extracting or homogenizing the sample. Yet comprehensive analysis of small, polar metabolites has remained difficult. These molecules ionize inefficiently under standard conditions, and their diverse chemical structures make them hard to capture in a single measurement. On-tissue chemical derivatization, or OTCD, has emerged as an effective strategy to improve ionization efficiency, sensitivity, and selectivity for exactly this class of analytes, and the new study systematically optimized that strategy for mouse tissue.

The team, led by Antonia Fecke, Luiza Martins Nascentes Melo, Ann-Cathrin Groba, Gabriele Allies, Feyza Cansiz, Siva Swapna Kasarla, Sven Heiles, Albert Sickmann, Alpaslan Tasdogan, and Karl W. Smith, established and optimized an OTCD approach for the spatial analysis of metabolites containing carbonyl and carboxyl groups. The researchers tuned reagent concentrations, solvent composition, and spray parameters until derivatization became reproducible across multiple tissue types, a prerequisite for any quantitative comparison between organs or between tumor and healthy regions.

Bromine has a characteristic isotopic signature, appearing naturally in two isotopes in a fixed ratio, and this signature transfers to every derivatized metabolite.

With the protocol in hand, the researchers applied it to biologically complex environments: metastatic liver and lung tissue from mouse models. In tumor-rich liver sections, the method revealed pronounced metabolic heterogeneity that correlated with histopathological features, meaning the molecular maps aligned with what a pathologist would see under the microscope. In lung tissue containing only small metastatic foci, the approach still produced clear tumor-specific localizations, demonstrating that the technique can resolve metabolic differences even when the tumor burden is minimal and spatially dispersed.

The authors emphasize that the method is capable of interrogating metabolic heterogeneity in clinically relevant tumor models, and they position the workflow as a foundation for future investigations of tumor metabolism rather than as a diagnostic tool in its own right.

According to the study, this is the first work to optimize and investigate sample preparation conditions for mouse tissue application of a reliable OTCD workflow using EDC and 4-APEBA for MALDI-MSI-based spatial metabolomics, with localized OTCD-MSI of melanoma metastases. By demonstrating reproducible derivatization across multiple tissue types, the researchers addressed a key source of technical artifact.

The study was published as open access research on 4 November 2026 and is currently shared as an early-access version, citable under a permanent DOI, with the final Version of Record to follow after further edits.

For the broader field, the significance is twofold.

Subject of Research: Optimized on-tissue chemical derivatization for MALDI-MSI spatial metabolomics of mouse organs and metastatic tumors using EDC and 4-APEBA

Article Title: Refined on-tissue chemical derivatization expands MALDI-MSI capabilities for spatial metabolomics of mammalian organs and metastatic tumors using EDC and 4-APEBA

Article References: Fecke, A., Melo, L. M. N., Groba, A.-C., Allies, G., Cansiz, F., Kasarla, S. S., Heiles, S., Sickmann, A., Tasdogan, A., & Smith, K. W. (2026). Refined on-tissue chemical derivatization expands MALDI-MSI capabilities for spatial metabolomics of mammalian organs and metastatic tumors using EDC and 4-APEBA. Cancer Cell International. https://doi.org/10.1186/s12935-026-04494-x

Image Credits: AI Generated

DOI: 10.1186/s12935-026-04494-x

Keywords: MALDI-MSI, spatial metabolomics, on-tissue chemical derivatization, 4-APEBA, EDC, tumor metabolism, metastasis, melanoma, glycolytic reprogramming, mass spectrometry imaging, mouse models, metabolites